• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, November 18, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Serum LMTK3 and SOX4 Predict Bladder Cancer Prognosis

by
November 9, 2026
in Health
Reading Time: 3 mins read
0
Serum LMTK3 and SOX4 Predict Bladder Cancer Prognosis

Serum LMTK3 and SOX4 Predict Bladder Cancer Prognosis

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A study published in BMC Urology reports that serum levels of two specific proteins, lemur tyrosine kinase 3 (LMTK3) and sex-determining region Y-box protein 4 (SOX4), are associated with the five-year prognosis of patients with bladder cancer. The research, conducted by Desheng Wang and Gaofei Lv, examined the predictive value of these biomarkers in a cohort of 142 patients. The findings suggest that higher concentrations of these proteins in the blood are linked to poorer survival outcomes and more advanced disease characteristics.

The study aimed to discuss the relationship between LMTK3, SOX4, and the prognosis of bladder cancer patients. To achieve this, the researchers included 142 patients with bladder cancer who were treated at their hospital between March 2015 and March 2020. The participants were divided into two groups based on their five-year prognosis: a survival group consisting of 101 patients and a death group consisting of 41 patients. This grouping allowed the researchers to compare clinical characteristics and biomarker levels between those who survived and those who did not over the five-year period.

The methodological approach involved collecting clinical characteristics from the patient records and performing enzyme-linked immunosorbent assays (ELISA) to measure serum levels of LMTK3 and SOX4. The researchers utilized multivariate Cox regression to identify independent prognostic factors. Additionally, they plotted receiver operating characteristic (ROC) curves to evaluate the predictive value of these indicators for patient prognosis. The Kaplan-Meier method was employed to analyze the relationship between the biomarker levels and the five-year survival rate, providing a statistical framework for comparing survival probabilities between different patient subgroups.

The results indicated that serum LMTK3 and SOX4 levels were significantly correlated with the T stage, N stage, M stage, and the presence of lymphovascular invasion in patients with bladder cancer, with all P-values less than 0.05. Specifically, the death group exhibited clearly higher serum levels of both LMTK3 and SOX4 compared to the survival group. Furthermore, the proportion of patients in the death group who had M1 stage disease or lymphovascular invasion was significantly higher than in the survival group, again with P-values less than 0.05. These associations suggest that elevated levels of these proteins are linked to more aggressive disease features and metastatic spread.

Statistical analysis revealed that M stage, lymphovascular invasion, LMTK3, and SOX4 were all independent risk factors for death in bladder cancer patients, with P-values less than 0.05. This means that even after accounting for other variables, higher levels of these serum proteins remained significantly associated with a higher risk of mortality. The independence of these factors highlights their potential utility as prognostic markers that provide additional information beyond standard clinical staging parameters.

The predictive performance of the biomarkers was assessed using area under the curve (AUC) values from ROC analysis. The AUC value for serum LMTK3 alone was 0.846, while the AUC for SOX4 alone was 0.801. When the two markers were combined, the AUC increased to 0.945. The difference in predictive accuracy between the combined model and the individual markers was statistically significant, with Z-values of 2.333 and 2.683, and P-values less than 0.05. This indicates that the combination of LMTK3 and SOX4 offers superior predictive value for prognosis compared to either marker used in isolation.

Survival analysis using the Kaplan-Meier method demonstrated that patients with high levels of LMTK3 and SOX4 had lower five-year survival rates compared to patients with low levels of these proteins. The log-rank chi-square values were 20.334 and 17.223, with P-values less than 0.05, confirming that the difference in survival curves between the high and low biomarker groups was statistically significant. These findings reinforce the association between elevated serum levels of LMTK3 and SOX4 and reduced long-term survival in bladder cancer patients.

The study concludes that LMTK3 and SOX4 have important reference value for the prognosis evaluation of bladder cancer patients. The data supports the idea that measuring these serum proteins could aid in risk stratification and prognosis prediction. However, it is important to note that the study was conducted at a single hospital and involved a relatively small sample size of 142 patients. The observational nature of the study establishes associations rather than causal relationships.

Subject of Research: Prognostic value of serum LMTK3 and SOX4 in bladder cancer

Article Title: The predictive value of serum LMTK3 and SOX4 for prognosis in patients with bladder cancer

Article References: Wang, D., & Lv, G. (2026). The predictive value of serum LMTK3 and SOX4 for prognosis in patients with bladder cancer. BMC Urology. https://doi.org/10.1186/s12894-026-02439-0

Image Credits: AI Generated

DOI: 10.1186/s12894-026-02439-0

Keywords: bladder cancer, prognosis, LMTK3, SOX4, biomarkers, survival rate, oncology, serum proteins, predictive, value, serum, patients

News Source: Nathaniel Bowman. (November 9, 2026). Serum LMTK3 and SOX4 Predict Bladder Cancer Prognosis. Scienmag.

Tags: biomarkersbladder cancerLMTK3Oncologypatientspredictiveprognosisserumserum proteinsSOX4survival ratevalue
Share12Tweet7Share2ShareShareShare1

Related Posts

Machine Learning Identifies Nine-Gene Macrophage Signature Predicting Lung Adenocarcinoma Prognosis

Machine Learning Identifies Nine-Gene Macrophage Signature Predicting Lung Adenocarcinoma Prognosis

November 18, 2026
Stone Burden and Location Predict Residual Fragments After Routine Kidney Ureteroscopy

Stone Burden and Location Predict Residual Fragments After Routine Kidney Ureteroscopy

November 18, 2026

Rural Oregon Trial Finds Colorectal Cancer Screening Dropped in Second Year

November 18, 2026

Recurrent Ischemic Strokes Cluster Within Six Months in Taiwanese ESUS Study

November 18, 2026

POPULAR NEWS

  • Coal Gangue Aggregates Can Replace Natural Stone in Concrete Applications

    Coal Gangue Aggregates Can Replace Natural Stone in Concrete Applications

    29 shares
    Share 12 Tweet 7
  • Cluster-Based Training Selection Outperforms Active Learning for Material Property Prediction

    29 shares
    Share 12 Tweet 7
  • Cesarean Section Rates Reached Forty Percent Among Surveyed Mothers in Njombe Region

    29 shares
    Share 12 Tweet 7
  • Testosterone Injections Exacerbate Pre-Neoplastic Prostate Lesions in NKX3.1-Deficient Mice

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Surface-Modified Carbon Nanotubes Enhance Cadmium Adsorption in Aqueous Testing

Machine Learning Identifies Nine-Gene Macrophage Signature Predicting Lung Adenocarcinoma Prognosis

Stone Burden and Location Predict Residual Fragments After Routine Kidney Ureteroscopy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.